CVS May 2020 72.500 call

OPR - OPR Delayed Price. Currency in USD
6.35
+0.21 (+3.42%)
As of 2:42PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close6.14
Open6.00
Bid6.20
Ask6.40
Strike72.50
Expire Date2020-05-15
Day's Range6.00 - 6.36
Contract RangeN/A
Volume12
Open Interest1.74k
  • Business Wire

    AM Best Affirms Credit Ratings of CVS Health Corporation’s Aetna Subsidiaries

    AM Best has affirmed the Financial Strength Rating of A and the Long-Term Issuer Credit Ratings of “a” of Aetna Life Insurance Company and the other operating entities of Aetna Inc.

  • 12 Dividend Stocks to Build a Monthly Income Calendar
    Kiplinger

    12 Dividend Stocks to Build a Monthly Income Calendar

    Most U.S. companies that pay dividends do it quarterly, or once every 90 days or so (foreign firms usually pay but once or twice a year). If your income stocks are on the same schedule, your payments will come much less regularly than, say, your relentless gas and electric bills.That's why many retirees and other dividend fans try to arrange matters so the income arrives more frequently. You can easily assemble a set of excellent dividend stocks with staggered pay dates. That's the idea of our Dividend-a-Month portfolio, assembled by the editors of Kiplinger's Investing for Income: cash every month, without interruption. You can play the calendar without dabbling in questionable stocks or worrying about the reliability of dividends.As a practical matter, note two key dates for dividend stocks. One is the "record date," the deadline to be a shareholder so you get the next payment. The record date is usually three to six weeks before the "payment date," which is when the dollars should appear in your brokerage account. We're using the actual arrival of the payment to match companies with their months. SEE ALSO: 14 High-Yield Dividend Stocks to Buy for the 4% Rule

  • The success of Medicare Advantage makes it a better policy choice than ‘Medicare for All’
    MarketWatch

    The success of Medicare Advantage makes it a better policy choice than ‘Medicare for All’

    It’s hunting season for health insurers, commonly referred to as “open enrollment.” People over 65 who turn on their TV or open their mailbox from late October through November can’t escape advertisements from private health insurers offering so-called Medicare Advantage plans on behalf of the federal government. The process may be mildly annoying, but it is a sign of vitality in a public-private partnership that is delivering high-quality health care at comparatively low cost. Over one-third of all Medicare beneficiaries now enroll in these plans.

  • Financial Times

    Insurers turn to wearable tech to nudge people towards healthier living

    The Texan business was one of the first to embrace a programme offered by United Healthcare, its health insurer, which uses devices such as the Apple Watch to push members into more physical activity. As well as the satisfaction of a win over colleagues, members get cash if they meet three targets: frequency of movement — getting up and walking for small periods often; intensity — at least one burst of 3,000 steps in 30 minutes; and tenacity, completing 10,000 steps in a day. Meeting each goal helps members earn between $1 and $3.

  • Should You Be Concerned About CVS Health Corporation's (NYSE:CVS) ROE?
    Simply Wall St.

    Should You Be Concerned About CVS Health Corporation's (NYSE:CVS) ROE?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

  • PR Newswire

    MinuteClinic Launches Video Visit Offering in Colorado

    WOONSOCKET, R.I., Nov. 19, 2019 /PRNewswire/ -- CVS Health (CVS) today announced that MinuteClinic, the company's retail medical clinic, has rolled out its video visit offering in the state of Colorado. People in Colorado with minor illnesses, minor injuries and skin conditions can now seek care through MinuteClinic Video Visits, a telehealth offering.

  • PR Newswire

    MinuteClinic Launches Video Visit Offering in New Jersey

    WOONSOCKET, R.I., Nov. 19, 2019 /PRNewswire/ -- CVS Health (CVS) today announced that MinuteClinic, the company's retail medical clinic, has rolled out its video visit offering in the state of New Jersey. People in New Jersey with minor illnesses, minor injuries and skin conditions can now seek care through MinuteClinic Video Visits, a telehealth offering.

  • PR Newswire

    MinuteClinic Launches Video Visit Offering in Illinois

    WOONSOCKET, R.I., Nov. 19, 2019 /PRNewswire/ -- CVS Health (CVS) today announced that MinuteClinic, the company's retail medical clinic, has rolled out its video visit offering in the state of Illinois. People in Illinois with minor illnesses, minor injuries and skin conditions can now seek care through MinuteClinic Video Visits, a telehealth offering.

  • The Extreme Risks of Trading Your Own Retirement Assets - November 15, 2019
    Zacks

    The Extreme Risks of Trading Your Own Retirement Assets - November 15, 2019

    From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.

  • Why Current Stock Market Highs Could Be A Warning Sign To Investors: Wealth Advisor
    Investor's Business Daily

    Why Current Stock Market Highs Could Be A Warning Sign To Investors: Wealth Advisor

    A financial advisor for high-net-worth clients shares why current stock market highs could be a warning sign to investors and how to manage market risk.

  • 3 REITs for Dividend Investors to Buy with Stock Market at New Highs
    Zacks

    3 REITs for Dividend Investors to Buy with Stock Market at New Highs

    Here are three highly-ranked REITs we found using our Zacks Stock Screener that dividend investors might want to buy with stock indexes at new highs...

  • Here's Why You Should Hold on to CVS Health (CVS) For Now
    Zacks

    Here's Why You Should Hold on to CVS Health (CVS) For Now

    Investors can still hold on to CVS Health (CVS) stock, thanks to its solid prospects.

  • Walgreens Boots Rallies on KKR's Bid but Market View Mixed
    Zacks

    Walgreens Boots Rallies on KKR's Bid but Market View Mixed

    Albeit the market sentiment is bullish on Walgreens Boots' (WBA) potential acquisition deal, many analysts are in doubt about the company's effective approach to get privatized.

  • CVS Health's New Plans With Aetna May Improve Health Outcomes
    Zacks

    CVS Health's New Plans With Aetna May Improve Health Outcomes

    CVS Health's (CVS) Health Care Benefits segment develops Medicare program with Aetna.

  • Want To Retire Early? Learn the Intelligent Investing Secret - November 13, 2019
    Zacks

    Want To Retire Early? Learn the Intelligent Investing Secret - November 13, 2019

    Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.

  • PR Newswire

    New Aetna Medicare programs help combat social isolation, improve health outcomes

    HARTFORD, Conn., Nov. 13, 2019 /PRNewswire/ -- Medical research shows that loneliness and social isolation are associated with negative health behaviors and a wide range of illnesses. In fact, the health impact of loneliness has been equated to smoking 15 cigarettes a day (Holt-Lunstad 2010). A 2019 University of Michigan study found that 34 percent of Americans aged 50 to 80 feel they lack companionship, while 27 percent feel isolated (University of Michigan 2019).

  • Morningstar

    Checkup for Healthcare Moats

    All of these companies now have narrow moats and stable moat trends. The U.S. health system continues to put significant financial pressure on many U.S. citizens, and we think medical insurers and pharmacy benefit managers will remain key targets of regulators looking to improve the U.S. healthcare system.

  • Barrons.com

    How KKR Could Pull Off a Walgreens Takeover

    Fund manager Bill Smead cites the availability of cheap financing, the drugstore chain’s strong earnings power, and possible participation by Berkshire Hathaway.

  • Walgreens Stock Surges On Formal Bid To Take Dow Jones Giant Private
    Investor's Business Daily

    Walgreens Stock Surges On Formal Bid To Take Dow Jones Giant Private

    Walgreens Boots Alliance stock gapped up after KKR reportedly made a formal offer to take the Dow Jones giant private.

  • CVS Health's Aetna Prospects Solid, Omnicare Sluggish
    Zacks

    CVS Health's Aetna Prospects Solid, Omnicare Sluggish

    CVS Health's (CVS) strong Pharmacy Services segment sales gain traction from growth in specialty services.

  • The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health
    Zacks

    The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health

    The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health

  • CVS Health Shares Gain Momentum on Positive Earnings
    Investopedia

    CVS Health Shares Gain Momentum on Positive Earnings

    As CVS expands its Minute Clinic to more store locations, going into this pharmacy will become like going into a "mini emergency room."

  • This Record Doesn’t Skip a Beat
    TipRanks

    This Record Doesn’t Skip a Beat

    The broader market average all closed at record highs on Friday, as U.S. stocks added to recent gains this week. Financial names led the way higher, while real estate and utility stocks trailed the market.Investors kept a close eye on trade talks between the U.S. and China this week. While a formal resolution has yet to be announced, multiple press reports suggested the two sides could announce a “Phase One” deal before the next set of tariffs are scheduled to take effect, on Dec. 15.Earnings Parade EndingThird-quarter earnings season effectively ended this week, as 446 companies in the S&P 500 index have now announced results. 74% of the names have exceeded expectations, which is above the historical average. On the other hand, aggregate profit is on track to decline 0.5% for the period.Kroger (KR) was the big earnings-related winner this week. The grocery retailer gained 11% a session after providing upbeat profit guidance. On the other hand, online travel names Expedia (EXPE) and TripAdvisor (TRIP) both lost more than 20% a day after disappointing the market with their respective quarterly results.Looking ahead to next week, Cisco Systems (CSCO), Viacom (VIAB) and Wal-Mart (WMT) are scheduled to post quarterly reports. The bond markets are closed on Nov. 9 for the Veterans Day holiday and the economic calendar will be relatively quiet next week. Knowing what and when to buy can be challenging for any investor. However, the fact remains that attractive investments are out there, if you’re willing to dig a little deeper.One such consumer name with strong earnings momentum is worth a closer look and is our Stock of the Week below… Stock of the Week: CVS Health (CVS)The company is probably best known for its portfolio of nearly 10,000 retail pharmacies, but acquisitions over the past several years have broadened its business portfolio.CVS Health provides medical insurance to 38 million users through Aetna and covers pharmacy benefits for 102 million customers, by way of Caremark. In addition, the company treats patients directly through its network of over 1,100 Minute Clinics.The stock gained nearly 8% this week, as management delivered better-than-expected quarterly results on Wednesday.Looking ahead, these gains should keep on coming. Here’s why:The retailer earned $1.84 a share in the third quarter, as revenue increased 36% from the previous year, to $64.81 billion. The sales growth was primarily from the Aetna acquisition, which is approaching its first anniversary. Management said on the conference call that all of the company’s core businesses grew at or above plan in the period.Following the results, 5-stare Cantor analyst Steven Halper raised his price target on the stock to $85, citing:> “In our view, CVS is executing on its strategy to integrate medical and pharmacy offerings to drive differentiation in the marketplace, through efforts such as HealthHUB expansion. Over time, we believe this should drive continued share gains and improvement in operating performance across the company's business units. As the company executes on these initiatives, share valuation should expand from current levels.” CVS Health generates steady cash flow, which it returns to investors. The shares offer a quarterly dividend of $0.25 a share (1.4% yield). Management also paid down $2.9 billion of net debt in the most recent quarter.In the meantime, the company is attractively priced at just 10.1x expected full-year earnings of $7.21 a share. This is an 11% discount to the median industry value and well below the average market multiple.It’s also worth noting that CVS Health carries a Smart Score of 10/10 on TipRanks. This new proprietary metric utilizes Big Data to rank stocks based on 8 key factors that have historically been a precursor of future outperformance.On top of the positive aspects mentioned already, Smart Score says the company has seen positive sentiment from investment bloggers and news.FYI: This is just 1 of the 20+ stocks selected for the Smart Investor portfolio. That’s where we share more detailed insights on our weekly stock picks. You may also want to learn more about how we use TipRanks indicators to find stocks that are primed to outperform. (Discover the Smart Investor portfolio here)

  • Top Analyst Reports for Mastercard, UnitedHealth & Merck
    Zacks

    Top Analyst Reports for Mastercard, UnitedHealth & Merck

    Top Analyst Reports for Mastercard, UnitedHealth & Merck

  • CVS Stock Finds Itself in a Good Place at a Bad Time
    InvestorPlace

    CVS Stock Finds Itself in a Good Place at a Bad Time

    CVS Health (NYSE:CVS) stock got a lift on Nov. 6 after delivering an earnings report that beat on both the top and bottom lines. The company also gave improved earnings estimates for the rest of 2019.Source: Shutterstock Earnings of $1.85 per share exceeded the consensus estimate of $1.77 per share. CVS also reported $64.8 billion in revenue which was above expectations of $62.99 billion. For the full year CVS gave an earnings per share (EPS) range between $6.97 and $7.05. This was an increase from their prior estimate of between $6.89 and $7.In a statement submitted with the earnings report, CEO Larry Merlo said, "Our third quarter results build on the positive momentum we have seen across the company since the beginning of the year. All of our core businesses performed in line with or above expectations, reflecting strong operational execution."InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Under-the-Radar Retail Stocks to Buy Now However the market hates uncertainty. And with the United States entering an election year, the only thing we know is what we don't know. Rising healthcare costs and insurance providers will be among the core issues. That means that CVS stock will likely be treading water as the company, and the industry, is faced with uncertainty. CVS Stock Underperforming the Broader MarketEven though the CVS stock price continues to climb the day after the earnings report, the stock is still down nearly 10% in the last 12 months. And it took until this last earnings report to push CVS stock into the black in 2019.This continues a trend. Over the last five years, CVS stock price is down 17.7%. The company will be spending a lot of their retained free cash flow (FCF) to pay down the debt from its acquisition of Aetna. And while the merging of the two companies has gone smoothly thus far, the syncing of the two organizations will be a question for investors throughout 2020.The company is also facing higher costs associated with renovating existing stores and shutting others. CVS closed 46 stores this year and is projected to close 22 more stores next year. A Complicated Business Just Added RiskCVS Health is the country's second-largest pharmacy chain behind Walgreens (NASDAQ:WBA). It is also the country's largest pharmacy in terms of total prescription revenue. One of the real stories behind the country's growth is that it has become one of the nation's largest pharmacy benefits managers (PBMs). The PBM business determines which drugs are covered for patients and negotiates price discounts with the pharmaceutical companies.In 2018, the company paid $40 billion to acquire Aetna, which put the company in the health insurance business. With this acquisition CVS believes it will be able to achieve even larger economies of scale. CVS already has some of the lowest per claim costs in the industry.CVS Health's PBM and drug distribution businesses were already exposed to political and regulatory risks. By adding health insurance to the mix, CVS has put itself more tightly in the crosshairs. Particularly as more attention is being given to healthcare costs.The Centers for Medicare and Medicaid Services project U.S. healthcare spending to rise to $6 trillion by 2027, a 5.5% annualized growth rate. In the short-term, this has been a lift for CVS earnings. However, rising healthcare costs are leading to further cries from public and private payers for companies to cut costs. This puts pressure on margins that are already thin. Is CVS Stock a Buy Right Now?I like CVS stock for income investors. The company has a dividend yield of near 3%. And with a forecast for modest, single-digit growth through 2020, the dividend should be safe. To be fair, CVS did end a 14-year history of dividend growth in 2018. After taking on $40 billion to purchase Aetna, the company is maximizing its FCF in order to deleverage its balance sheet.But the stock is not a good play for growth investors. The company has a good valuation at just under 10 times projected earnings. However, prior to its most recent earnings report, CVS stock was negative for the year. Even with the surge, CVS Health stock is up just over 10% in 2019.And many of the same industry pressures remain. The industry still is facing government scrutiny of drug prices. There is ongoing pressure as Amazon (NASDAQ:AMZN) continues to become a larger presence in the pharmaceutical delivery space.CVS has been a solid performer with good management. Its recent acquisition of Aetna is a bold move that, while it contains risks, is another example of the company's intention to provide good value to its shareholders. And that may prove to be the case, but I don't see a strong growth story for the stock in the next year.As of this writing, Chris Markoch did not have a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks to Sell Before They Roll Over * 5 Beaten-Up Stocks to Buy That Could Be Saved By An Acquisition * 4 Startup Stocks Getting Smashed The post CVS Stock Finds Itself in a Good Place at a Bad Time appeared first on InvestorPlace.